<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PI3K/PDK1/SGK3 pathway &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pi3k-pdk1-sgk3-pathway/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 24 Nov 2025 09:51:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>PI3K/PDK1/SGK3 pathway &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>C3a Enhances Osteoclast Formation in Multiple Myeloma</title>
		<link>https://bioengineer.org/c3a-enhances-osteoclast-formation-in-multiple-myeloma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 24 Nov 2025 09:51:20 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[C3a complement]]></category>
		<category><![CDATA[multiple myeloma]]></category>
		<category><![CDATA[osteoclast formation]]></category>
		<category><![CDATA[PI3K/PDK1/SGK3 pathway]]></category>
		<category><![CDATA[Sirt1 inhibition]]></category>
		<guid isPermaLink="false">https://bioengineer.org/c3a-enhances-osteoclast-formation-in-multiple-myeloma/</guid>

					<description><![CDATA[In a groundbreaking exploration of the complex mechanisms behind multiple myeloma, researchers Jiang, Zhang, and Peng have uncovered an intriguing relationship between complement component C3a and the formation of osteoclasts. This research sheds new light on the biological pathways that govern bone resorption, a critical aspect of multiple myeloma pathology. The findings were recently published [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">300460</post-id>	</item>
	</channel>
</rss>
